Aclaris Therapeutics, Inc. (ACRS) Capital expenditures 2016–2025
Aclaris Therapeutics, Inc. (ACRS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$111,000FY2025 · since FY2016: $232,000 → $111,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $111,000 | -8.3% |
| FY2024 | $121,000 | -90.8% |
| FY2023 | $1.3M | +116.4% |
| FY2022 | $605,000 | +96.4% |
| FY2021 | $308,000 | -32.0% |
| FY2020 | $453,000 | -71.9% |
| FY2019 | $1.6M | +19.0% |
| FY2018 | $1.4M | +9.8% |
| FY2017 | $1.2M | +432.3% |
| FY2016 | $232,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice